Incontinence-associated dermatitis Made Easy
Incontinence-associated dermatitis (IAD) has a significant impact on the lives of the patients it affects. It poses a major healthcare challenge: it is difficult and time-consuming to treat and is a well-documented risk factor for pressure ulcer development. Current lack of standard terminology, and the difficulty in recognising the condition and distinguishing it from Category I/II pressure ulcers are just some of the challenges clinicians face in treatment and management of IAD. This Made Easy looks at ways to overcome the current hurdles to improve diagnosis, assessment and treatment, and to boost outcomes for patients.
Supported by Medline